„Narrow-band-imaging-assistierte" Zystoskopie in der Blasentumornachsorge

详细信息    查看全文

• 作者：L. Hirner ; E. Stagge ; H. Rübben ; M. Schenck ; A. Eisenhardt
• 关键词：Urethrocystoscopy ; Carcinoma ; invasive nonmuscle ; White light cystoscopy ; Vascularization ; Tumor detection rate
• 刊名：Der Urologe A
• 出版年：2016
• 出版时间：March 2016
• 年：2016
• 卷：55
• 期：3
• 页码：370-375
• 全文大小：296 KB
• 参考文献：1.Babjuk M, Oosterlinck W, Silvester R et al (2011) EAU guidelines on non-muscle-invasive urothelial carcinoma oft he bladder the 2011 update. Eur Urol 59:997–1008CrossRef PubMed
  2.Brausi M, Collette L, Kurth K et al (2002) Variability in the recurrence rate at first follow-up cystocopy after TUR in stage Ta T1 transitional cell carcinoma of the bladder: a combined analysis of seven EORTC studies. Eur Urol 41:523–553CrossRef PubMed
  3.Cauberg EC, Bruin DM de, Faber DJ et al (2009) A new generation of optical diagnostics for bladder cancer: technology, diagnostic accuracy, and future applications. Eur Urol 56(2):287–296CrossRef PubMed
  4.Cauberg E, Mamoulakis C, Rosette J de la et al (2011) Narrow band imaging-assisted transurethral resection for non-muscle invasive bladder cancer significantly reduces residual tumour rate. World J Urol 29:503–509CrossRef PubMed PubMedCentral
  5.Chiu HM, Chang CY, Chen CC et al (2007) A prospective comparative study of narrow-band imaging, chromoendoscopy, and conventional colonoscopy in the diagnosis of colorectal neoplasia. Gut 56(3):373–379CrossRef PubMed PubMedCentral
  6.Daniltchenko DI, Riedl CR, Sachs MD et al (2005) Long term benefit of 5-aminolevulinic acid fluorescence assisted transurethral resection of superficial bladder cancer: 5-year results of a prospective randomized study. J Urol 174:2129–2133CrossRef PubMed
  7.Geavlete B, Stănescu F, Moldoveanu C et al (2013) NBI cystoscopy and bipolar electrosurgery in NMIBC management – an overview of daily practice. J Med Life 6(2):140–145PubMed PubMedCentral
  8.Herr HW, Donat SM, Dalbagni G et al (2010) Narrow-band imaging cystoscopy to evaluate bladder tumours – individual surgeon variability. BJU Int 106:53–55CrossRef PubMed PubMedCentral
  9.Herr HW, Donat SM (2008) A comparison of white-light cystoscopy and narrow-band imaging cystoscopyto detect bladder tumour recurrences. BJU Int 102:1111–1114CrossRef PubMed
  10.Jakse G, Algaba F, Malmström PU et al (2004) A second-look TUR in T1 transitional cell carcinoma: why? Eur Urol 45:539–546CrossRef PubMed
  11.Li K, Lin T, Fan X et al (2013) Diagnosis of narrow-band imaging in non-muscle-invasive bladder cancer: a systematic review and meta-analysis. Int J Urol 20:602–609CrossRef PubMed
  12.Kara M, Peters FP, Fockens P et al (2006) Endoscopic video-autofluorescence imaging followed by narrow-band imaging for detecting early neoplasia in Barrett’s esophagus. Gastrointest Endosc 64(2):176–185CrossRef PubMed
  13.Naselli A, Introini C, Timossi L et al (2012) A randomized prospective trial to assess the impact of transurethral resection in narrow band imaging modality on non–muscle-invasive bladder cancer recurrence. Eur Urol 61:908–913CrossRef PubMed
  14.Bryan RT, Billingham LJ, Wallace DMA (2008) Narrow-band imaging flexible cystoscopy in the detection of recurrent urothelial cancer of the bladder. BJU Int 101:702–706CrossRef PubMed
  15.Robert-Koch-Institut (Hrsg) und Gesellschaft der epidemiologischen Krebsregister in Deutschland e. V., Berlin (2008) „Krebs in Deutschland 2003–2004“, 6. Aufl. RKI, Berlin
  16.Schumacher MC, Holmäng S, Davidsson T et al (2010) Transurethral resection of non-muscle invasive bladder transitional cell cancers with or without 5-aminolevulinic acid under visible and fluorescence light: results of a prospective, randomised, multicentre study. Eur Urol 57:293–299CrossRef PubMed
  17.Shen YI, Zhu YP, Ye DW et al (2012) Narrow-band imaging flexible cystoscopy in the detection of primary non-muscle invasive bladder cancer: a „second look“ matters? Int Urol Nephrol 44:451–457CrossRef PubMed
  18.Sobin LH, Gospodarowicz MK, Wittekind C (2009) TNM classification of malignant tumors, 7. Aufl. Wiley-Blackwell, New York
  19.Stenzl A, Penkhoff H, Dajc-Sommerer E et al (2011) Detection and clinical outcome of urinary bladder cancer with 5-aminolevulinic acid-induced fluorescence cystocsopy: a multicentre randomized, double-blind, placebo-controlled trial. Cancer 117:938–947CrossRef PubMed
  20.Tatsugami K, Kuroiwa K, Kamoto T et al (2010) Evaluation of narrow-band imaging as a complementary method for the detection of bladder cancer. J Endourol 24(11):1807–1811CrossRef PubMed
  21.Zheng C, Lv Y, Zhong Q et al (2012) Narrow band imaging diagnosis of bladder cancer: systematic review and meta-analysis. BJU Int 110(11 Pt B):680–687CrossRef
  
• 作者单位：L. Hirner (1) (2)
  E. Stagge (2)
  H. Rübben (1)
  M. Schenck (1)
  A. Eisenhardt (1) (2)
  
  1. Klinik und Poliklinik für Urologie, Uroonkologie und Kinderurologie, Universitätsklinikum Essen, Hufelandstraße 55, 45122, Essen, Deutschland
  2. Praxisklinik Urologie Rhein-Ruhr, Mülheim a.d. Ruhr, Deutschland
  
• 刊物类别：Medicine
• 刊物主题：Medicine & Public Health
  Urology and Andrology
  
• 出版者：Springer Berlin / Heidelberg
• ISSN：1433-0563

文摘

Background Narrow band imaging (NBI) is a new technique of urethrocystoscopy, in which only certain wavelengths [415 (blue) and 540 nm (green)] are used to detect urothelial carcinoma. The aim of the investigation was to analyze the potential benefit of NBI in the follow-up of patients with transitional cell carcinoma of the bladder.